Publication Date
5-3-2024
Content Type
Article
PubMed ID:
Citation
Odia, Y., Hall, M. D., Cloughesy, T. F., Wen, P. Y., Arrillaga-Romany, I., Daghistani, D., Mehta, M. P., Tarapore, R. S., Ramage, S. C., & Allen, J. E. (2024). Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Neuro-oncology, 26(Supplement_2), S165–S172. https://doi.org/10.1093/neuonc/noae021
Restricted
Available to BHSF community via local IP address or BHSF login.